Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells

Fluoxetine affects antioxidant system and promotes apoptotic signaling in Wistar rat liver

(2011) Jelena Djordjevic et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice

(2011) Luciana Romina Frick et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Development of stealth liposome coencapsulating doxorubicin and fluoxetine

(2011) Jasmine Chiat-Ling Ong et al.   JOURNAL OF LIPOSOME RESEARCH

Fluoxetine Up-Regulates Bcl-xL Expression in Rat C6 Glioma Cells

(2011) Mi Ran Choi et al.   Psychiatry Investigation

Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine

(2010) Krishnan Rathinasamy et al.   BMC CANCER

HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM

(2010) Juan Cen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma

(2010) Suzanne M. Cloonan et al.   INTERNATIONAL JOURNAL OF CANCER

Multiple Drug Resistance Mechanisms in Cancer

(2010) Bruce C. Baguley   MOLECULAR BIOTECHNOLOGY

A Review of Mechanisms of Circumvention and Modulation of Chemotherapeutic Drug Resistance

(2009) R. O'Connor   CURRENT CANCER DRUG TARGETS

Pharmacological activation of the p53 pathway in haematological malignancies

(2009) M. N Saha et al.   JOURNAL OF CLINICAL PATHOLOGY

Treatment of resistant human colon cancer xenografts by a fluoxetine–doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen

(2008) Mirit Argov et al.   CANCER LETTERS

Reversal of Multidrug Resistance by Synthetic and Natural Compounds in Drug-Resistant MCF-7 Cell Lines

(2008) Meltem Demirel Kars et al.   CHEMOTHERAPY